Peter Briger is a financial executive who is among the top billionaires. He is currently a member of the Forbes list of billionaires after accumulating a great deal of wealth during his career. During the last two decades, Peter has served in top managerial roles at two highly successful investment firms. While working at these firms, Peter was able to help them grow an develop an international presence. As well as leading a couple of top investment firms, Peter has been involved in helping his community. On a regular basis, he helps contribute to a number of causes that help make the community a better place.
The most recent career experience of Peter Briger is his stint at Fortress Investment Group. Briger joined the firm in the year 2002 and has held key leadership roles at the firm since he began working here. Today, Peter is one of the chief executive officers and the principal of the firm. At these positions, Peter provides his expertise and leadership to help provide essential strategy for the firm’s operations. As well as being the chief executive officer and principal, Briger is also a member of the firm’s management committee. For over a decade, Peter Briger was a member of Goldman Sachs.
As a member of one of the top investment firms in the world, Peter was able to establish himself as a top finance professional. He served in key managerial roles at Goldman Sachs which culminated in his appointment to partner in the mid 1990’s. While he was at Goldman Sachs, Peter helped the firm make key client acquisitions in Asia. Briger supervised numerous investment professionals who were responsible for assisting clients in Asia with investment strategies. Over the last two decades, Peter Briger has been a regular contributor to his community. When he was based in New York City, Briger helped maintain and improve the Central Park Conservatory. This project allowed the park to become even more of a top tourist attraction in the city. In San Francisco, Peter would make valuable contributions to the city’s housing crisis. Briger helped a number of low income families get affordable housing. With these contributions, Peter has been able to make a difference in his locale.
Marathon Pharmaceuticals is a company that specializes in developing as well as launching brand new treatments of diseases that are quite rare in nature. They are focused on hard-to manufacture medications and make them available to their patients with limited treatment options. They are also investigating numerous treatments for neurological disorders, rare cancers, and other ailments too.
Marathon Pharmaceuticals has offices in New Jersey and is headquartered in Northbrook, Illinois. Their Chicago facility is used to find new therapies for central nervous system diseases, cancer, endocrine deficiencies, and gastrointestinal diseases. Their Bioscience Center is located in close proximity to MATTER which is a hub for healthcare start-ups and biotechnology.
Marathon Pharmaceuticals is able to manufacture medications such as Amytal Sodium which can be difficult to manufacture. Amytal Sodium is a barbiturate derivative that is a sedative hypnotic. It is used to decrease motor activity and is also effective in producing drowsiness, sedation, and hypnosis. It is a short-term treatment for insomnia. They also manufacture Amytal Sodium which is another type of barbiturate derivative. It is used as a pre-anesthetic before a surgery.
PEPCID® is another product that they manufacture, and it is used to reduce stomach acid in patients. It is also a short-term treatment of ulcers and gastroesophageal reflux disease. They are well known for launching ZINGO which is a powder intradermal injection system. It is used primarily by children between the ages of three and 13 who have a difficult time with needle insertions.
In order to distribute ZINGO, Marathon Pharmaceuticals has joined forces with Medline. Medline is a global distributor of clinical solutions as well as medical supplies. According to Luke Stevens, President of the Nutrition and Pharmaceuticals Division of Medline, the collaboration has made it possible for the best in the healthcare industry to become more focused on patient care.
The companies are working on the same wavelength and will now be able to deliver ZINGO to patients who need it. They’ll be able to keep up with the demand for the product and ZINGO will be brought to medical centers, children’s hospitals, and community hospitals.
Jeff Aronin is a man with a heart of gold. He is an innovator and executive at Paragon Biosciences. Paragon Biosciences incubates innovative companies at the forefront of development and research to help individuals suffering from uncommon diseases, or illnesses, that currently have no treatment options available. Aronin’s main objective is to help people and make their lives easier. He is a well-known executive and entrepreneur who has inspired many in the healthcare industry and beyond.
Aronin graduated with a bachelors degree from Northern Illinois University. He also attained his MBA when he attended DePaul University. He is invested in finding treatments for those suffering from conditions that have not been adequately addressed by larger pharmaceutical companies or the healthcare industry in general. As of recent, Aronin and his team have contributed 14 new medications to the pharmaceutical. Jeff takes the necessary steps in order to aid the research and development of Paragon’s portfolio companies by providing financial assistance and strategic guidance.
After 20 years of working in the pharmaceutical industry, one of Jeff’s first successes was Ovation Pharmaceuticals which was later sold for $900 Million. Throughout his career, Jeff has earned plenty of awards and aims to provide those whose time are finite gain longevity. He has helped create a portfolio of multiple companies that he invests in, and provides them with groundbreaking assets. Jeff Aronin is the prime example of a humanitarian, his hard work and dedication will change the future of medicine and many lives to come.
Jeff Aronin is a member of the executive committee of World Business Chicago and a board member of Discover Financial Services as well non-executive chairman of several of Paragon’s portfolio companies. Jeff is working towards developing economic growth and creating more jobs for the community of Chicago.
There was a time when startup companies in Japan are struggling to grow, because of the lack of support from the public. The idea to create a company with innovative objectives is unpopular in Japan, but everything changed after William Saito introduced the potential of the industry to a lot of Japanese people. William Saito is a tech entrepreneur, and he moved to Japan back in the year 2004. Before his migration to the Asian country, he used to manage his businesses in the United States. During his early years in the field of computers, he developed the I/O Software which displays English and Japanese languages interchangeably throughout the monitor screen. It provided convenience to American and Japanese computer engineers who are working together for a project, and Microsoft later bought the technology.
The decision to move to Japan came in 2004 when he realized that the country would need to go under a massive reform when it comes to empowering the youth about startups. He wanted a Japanese to develop the next Facebook, and so he started to inspire the youth and encouraged them to do something great. While he was staying in Japan, William Saito established a business called the Creative Lounge Mov. It is a facility similar to an office where Japanese people could go freely inside and use their computers to do their projects. William Saito believes that encouraging the youth to do their projects in a safe and convenient place would give birth to more ideas that could help the society someday.
Aside from managing the Creative Lounge Mov, William Saito is also visiting the major cities across the country to host conferences and seminars about the importance of engaging in startup businesses. He claimed that the Japanese people tend to provide more attention to their infrastructure projects and office jobs, but there is a growing number of Japanese individuals who are looking at the startup industry as the next big thing in the country. William Saito and a group of Japanese entrepreneurs are discussing the possibility of establishing new startups that would serve as a guide for the public.